Cognitive functioning in thyroid cancer survivors: a systematic review and meta-analysis
Some thyroid cancer (TC) survivors experience cognitive symptoms.
The purpose of this study is to perform a systematic literature review and meta-analysis comparing cognitive performance in TC survivors to controls.
We performed a seven-database electronic search and hand-search. We performed duplicate independent reviews and data abstraction. Random effects meta-analyses reported standardized mean differences (SMDs) with 95% confidence intervals (CIs), where a negative value implies worse performance in the TC group.
We reviewed 1174 unique citations and 10 full-text papers. We included seven studies of 241 treated TC survivors and 273 controls. Cognitive function was statistically significantly worse in TC survivors in the following domains: Attention and Concentration (Digit Span Forwards) SMD − 0.37 (95% CI − 0.62, − 0.13, p = 0.003, four studies), Speed of Processing (Trail Making A) SMD − 0.36 (95% CI − 0.66, − 0.05, p = 0.022, four studies), and Language (Controlled Oral Word Association [COWAT]-Categories) SMD − 0.97 (95% − 1.31, − 0.64, p < 0.001, two studies). Executive Function results varied: COWAT-Letters SMD − 0.60 (95% CI − 0.94, − 0.27, p < 0.001, two studies), Digit Span Backwards SMD − 0.40 (95% CI − 0.64, − 0.15, p = 0.002, four studies), and Trail Making B test SMD − 0.20 (95% CI − 0.51, 0.10, p = 0.191, four studies). Statistical heterogeneity limited the COWAT-Categories and Digit Span Backwards meta-analyses.
Cognitive function was worse in TC survivors in multiple domains. Limitations included few studies, potential confounding, and lack of prospective data.
Implications for Cancer Survivors
TC survivors may experience impairments in cognitive function and should report cognitive concerns to healthcare practitioners.
KeywordsNeurocognitive function Cancer survivorship Thyroid cancer Systematic review Meta-analysis
AMS was supported, in part, by a University of Toronto Department of Medicine Clinician Scientist Merit Award. The authors would like to thank Mrs. Coreen Marino, for assistance in retrieving the full-text papers for review. The authors would also like to thank Drs. Jan Jaracz and Moira A. Visovatti, for kindly responding to our queries about their studies.
Library service expenses were funded, in part, from a University Health Network Thyroid Cancer Research Fund (private charitable donations to the UHN Foundation).
Compliance with ethical standards
Conflict of interest
The authors declare that they have no conflict of interest.
- 2.International Agency for Research on Cancer 2017 GLOBOCAN 2012: Estimated cancer incidence, mortality, and prevalence worldwide in 2012. Available at http://globocan.iarc.fr/Pages/fact_sheets_population.aspx Accessed July 18, 2018.
- 4.Rosenthal K. When cancer muddles the mind. 2009 New York Times. Available at: https://well.blogs.nytimes.com/2009/11/17/when-cancer-muddles-the-mind/ Accessed July 18, 2018.
- 5.Joly F, Giffard B, Rigal O, De Ruiter MB, Small BJ, Dubois M, et al. Impact of cancer and its treatments on cognitive function: advances in research from the Paris International Cognition and Cancer Task Force Symposium and Update since 2012. J Pain Symptom Manag. 2015;50(6):830–41.CrossRefGoogle Scholar
- 21.Jaracz J, Kucharska A, Rajewska-Rager A, Lacka K. Cognitive functions and mood during chronic thyrotropin-suppressive therapy with L-thyroxine in patients with differentiated thyroid carcinoma. J Endocrinol Investig. 2012;35(8):760–5.Google Scholar
- 27.Zer A, Pond GR, Razak ARA, Tirona K, Gan HK, Chen EX, et al. Association of neurocognitive deficits with radiotherapy or chemoradiotherapy for patients with head and neck cancer. JAMA Otolaryngol Head Neck Surg. 2018;144:71–9.Google Scholar
- 34.Morote J, Tabernero ÁJ, Álvarez Ossorio JL, Ciria JP, Domínguez-Escrig JL, Vázquez F, et al. ANAMEM Investigator Group. Cognitive function in patients with prostate cancer receiving luteinizing hormone-releasing hormone analogues: a prospective, observational, multicenter study. Int J Radiat Oncol Biol Phys. 2017;98(3):590–4.CrossRefGoogle Scholar
- 35.Tae BS, Jeon BJ, Shin SH, Choi H, Bae JH, Park JY. Correlation of androgen deprivation therapy with cognitive dysfunction in patients with prostate cancer: a nationwide population-based study using the National Health Insurance Service Database. Cancer Res Treat 2018. doi: https://doi.org/10.4143/crt.2018.119.
- 49.Higgins JPT, Green S. 2011 Recommendations for testing of funnel plot asymmetry. Cochrane handbook for systematic reviews of interventions. Version 5.1.0 Available at: http://handbook-5-1.cochrane.org/chapter_10/10_4_3_1_recommendations_on_testing_for_funnel_plot_asymmetry.htm Accessed January 31, 2019.